Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caris Life Sciences (CAI) Other Non Operating Income (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Other Non Operating Income data on record, last reported at -$2.1 million in Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 8026.92% year-over-year to -$2.1 million; the TTM value through Dec 2025 reached -$20.4 million, changed N/A, while the annual FY2025 figure was -$20.6 million, 5791.12% down from the prior year.
  • Other Non Operating Income reached -$2.1 million in Q4 2025 per CAI's latest filing, up from -$18.3 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $37000.0 in Q3 2024 and bottomed at -$18.3 million in Q2 2025.